Psychosocial assessment of potential retinal prosthesis trial participants

REFERENCES

• da Cruz L, Dorn JD, Humayun MS et al. Five‐year safety and performance results from the Argus II retinal prosthesis system clinical trial. Ophthalmology 2016; 123: 2248–2254.
   PubMed Web of Science ®Google Scholar
• Stingl K, Bartz‐schmidt KU, Besch D et al. Subretinal visual implant alpha IMS clinical trial interim report. Vision Res 2015; 111: 149–160.
   PubMed Web of Science ®Google Scholar
• Stingl K, Schippert R, Bartz‐schmidt KU et al. Interim results of a multicenter trial with the new electronic subretinal implant alpha AMS in 15 patients blind from inherited retinal degenerations. Front Neurosci 2017; 11: 445.
   Web of Science ®Google Scholar
• Keseru M, Feucht M, Bornfeld N et al. Acute electrical stimulation of the human retina with an epiretinal electrode array. Acta Ophthalmol 2012; 90: e1–e8.
   PubMed Web of Science ®Google Scholar
• Ayton LN, Blamey PJ, Guymer RH et al. First‐in‐human trial of a novel suprachoroidal retinal prosthesis. PLoS One 2014; 9: e115239.
   Web of Science ®Google Scholar
• Lane FJ, Huyck M, Troyk P et al. Responses of potential users to the intracortical visual prosthesis: final themes from the analysis of focus group data. Disabil Rehabil Assist Technol 2012; 7: 304–313.
   PubMedGoogle Scholar
• Lane FJ. Methods and results from interviews of eleven recipients of a visual cortex implant: an analysis of their experiences. The Eye and the Chip: World Congress on Artificial Vision. Detroit, Michigan, 2012.
   Google Scholar
• Lane FJ, Nitsch K, Huyck M et al. Perspectives of optic nerve prostheses. Disabil Rehabil Assist Technol 2016; 11: 301–309.
   PubMed Web of Science ®Google Scholar
• Cure Research. Statistics by Country for Retinitis Pigmentosa. [Internet] Cure for Research. 2005 – [Cited 2018 Aug 20.] Available from: http://www.cureresearch.com/r/retinitis_pigmentosa/stats-country_printer.htm
   Google Scholar
• Chaumet‐riffaud AE, Chaumet‐riffaud P, Cariou A et al. Impact of retinitis pigmentosa on quality of life, mental health, and employment among young adults. Am J Ophthalmol 2017; 177: 169–174.
   PubMed Web of Science ®Google Scholar
• Zhang X, Bullard KM, Cotch MF et al. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005‐2008. JAMA Ophthalmol 2013; 131: 573–581.
   PubMed Web of Science ®Google Scholar
• Jangra D, Ganesh A, Thackray R et al. Psychosocial adjustment to visual loss in patients with retinitis pigmentosa. Ophthalmic Genet 2007; 28: 25–30.
   PubMed Web of Science ®Google Scholar
• Cimarolli VR, Boerner K, Reinhardt JP et al. A population study of correlates of social participation in older adults with age‐related vision loss. Clin Rehabil 2017; 31: 115–125.
   PubMed Web of Science ®Google Scholar
• Latham K, Baranian M, Timmis M et al. Emotional health of people with visual impairment caused by retinitis pigmentosa. PLoS One 2015; 10: e0145866.
   Web of Science ®Google Scholar
• Bailey IL, Jackson AJ, Minto H et al. The Berkeley rudimentary vision test. Optom Vis Sci 2012; 89: 1257–1264.
   PubMed Web of Science ®Google Scholar
• Rondinelli R, Genovese E, Mayer T et al. Guides to the Evaluation of Permanent Impairment. Chicago: American Medical Association, 2008.
   Google Scholar
• Costa PT, Mccrae RR. NEO Inventories Professional Manual: NEO‐PI‐3, NEO‐FFI‐3, NEO PI‐R. Lutz, Florida: Psychological Assessment Resources Inc., 2010.
   Google Scholar
• Costa PT Jr, Mccrae RR. Domains and facets: hierarchical personality assessment using the revised NEO personality inventory. J Pers Assess 1995; 64: 21–50.
   PubMed Web of Science ®Google Scholar
• Mccrae RR, Martin TA, Costa PT Jr. Age trends and age norms for the NEO Personality Inventory‐3 in adolescents and adults. Assessment 2005; 12: 363–373.
   PubMed Web of Science ®Google Scholar
• Canivez GL, Watkins MW. Investigation of the factor structure of the Wechsler Adult Intelligence Scale‐‐Fourth Edition (WAIS‐IV): exploratory and higher order factor analyses. Psychol Assess 2010; 22: 827–836.
   PubMed Web of Science ®Google Scholar
• Wechsler D. Wechsler Adult Intelligence Scale ‐ Fourth Edition Administration and Scoring Manual. Santonio, Texas: Pearson Education Inc., 2008.
   Google Scholar
• Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991; 32: 705–714.
   PubMed Web of Science ®Google Scholar
• Schwarzer R, Jerusalem M. Generalized self‐efficacy scale. In: Weinman J, Wright S, Johnston M, eds. Measures in Health Psychology: A User's Portfolio Causal and Control Belief. Windsor: NFER‐NELSON, 1995. pp. 35–37.
   Google Scholar
• Brennan‐ing M, Boerner K, Horowitz A et al. The vision‐specific optimization in primary and secondary control (OPS) scale. Eur J Ageing 2013; 10: 345–352.
   Web of Science ®Google Scholar
• Rovner BW, Casten RJ, Massof RW et al. Psychological and cognitive determinants of vision function in age‐related macular degeneration. Arch Ophthalmol 2011; 129: 885–890.
   PubMedGoogle Scholar
• Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self‐mastery, and self‐esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 1994; 67: 1063–1078.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ‐9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606–613.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self‐report version of PRIME‐MD: the PHQ primary care study. JAMA 1999; 282: 1737–1744.
   PubMed Web of Science ®Google Scholar
• Lamoureux EL, Pallant JF, Pesudovs K et al. The impact of vision impairment questionnaire: an evaluation of its measurement properties using Rasch analysis. Invest Ophthalmol Vis Sci 2006; 47: 4732–4741.
   PubMed Web of Science ®Google Scholar
• Lamoureux EL, Pallant JF, Pesudovs K et al. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis. Invest Ophthalmol Vis Sci 2007; 48: 1001–1006.
   PubMed Web of Science ®Google Scholar
• Misajon R, Hawthorne G, Richardson J et al. Vision and quality of life: the development of a utility measure. Invest Ophthalmol Vis Sci 2005; 46: 4007–4015.
   PubMed Web of Science ®Google Scholar
• Peacock S, Misajon R, Iezzi A et al. Vision and quality of life: development of methods for the VisQoL vision‐related utility instrument. Ophthalmic Epidemiol 2008; 15: 218–223.
   PubMed Web of Science ®Google Scholar
• Sugawara T, Hagiwara A, Hiramatsu A et al. Relationship between peripheral visual field loss and vision‐related quality of life in patients with retinitis pigmentosa. Eye (Lond) 2010; 24: 535–539.
   PubMed Web of Science ®Google Scholar
• Wright SE, Mccarty CA, Burgess M et al. Vision impairment and handicap: the RVIB Employment Survey. Aust N Z J Ophthalmol 1999; 27: 204–207.
   Google Scholar
• Nyman SR, Gosney MA, Victor CR. Psychosocial impact of visual impairment in working‐age adults. Br J Ophthalmol 2010; 94: 1427–1431.
   PubMed Web of Science ®Google Scholar
• Duncan JL, Richards TP, Arditi A et al. Improvements in vision‐related quality of life in blind patients implanted with the Argus II epiretinal prosthesis. Clin Exp Optom 2017; 100: 144–150.
   Web of Science ®Google Scholar